Mats L. Wahlstrom
Independent ChairmanMr. Mats L. Wahlstrom is Partner & Co-Chairman of Hw Investment Partners, LLC. He serves as the Executive Chairman, Chief Executive Officer & Partner of KMG Capital Partners, LLC since April 2012. He serves as the Co-Chairman of Breakout Investment Partners, LLC. Mr. Wahlstrom served as Senior Advisor to the Chairman of the Management Board of Management AG at Fresenius Medical Care AG & Co. KGAA. He served as co-Chief Executive Officer of Fresenius Medical Care North America (FMCNA) from January 2004 to December 2009 and President and Chief Executive Officer of Fresenius Medical Services from November 2002 to December 2009. He serves as Independent Chairman at TriSalus Life Sciences, Inc. since November 30, 2016. He has experience in the healthcare industry, having served as CEO and CFO of large international companies in the medical field. He served as Co-Chief Executive Officer of Services Division at Fresenius Medical Care Holdings Inc. He served as President of DVA Renal Healthcare, Inc. Prior to joining Fresenius Medical Care in 2002, he held various positions at Gambro AB in Sweden from january 1983 to february 2000, including President of Gambro North America and Chief Executive Officer of Gambro Healthcare Inc. as well as Chief Financial Officer of the Gambro Group. He has been the Chairman at Surefire Medical, Inc since January 2017. He serves as the Chairman of Caduceus Medical Holdings, Inc since August 2010. He serves as Chairman and Chairman of Board of Managers of HealthDev since August 2010. He serves as Chairman of DVA Renal Healthcare, Inc. and has been its Director since May 1991. He served as Chairman and Chairman of Board of Managers at Physicians' Capital Investments, LLC. He serves as a Director at PCI.He served as a Director at Getinge AB from March 2012 to March 2017. He serves as a Director at Circuit Clinical Solutions, Inc. since July 2016. He serves as a Director at Physicians' Capital Investments, LLC and served as a Director at Alteco Medical AB since October 2012 until 2025. He has been a Director of Coherus Oncology, Inc. (formerly known as Coherus BioSciences, Inc.) since January 2012 and serves as its Lead Independent Director. He serves as Chairman of Triomed AB since October 2016. He serves as a Director at Circuit Clinical, Inc. He serves as a Member of Advisory Board at MDValuate, Inc. He served as a Director of Zynex, Inc. from October 18, 2010, to January 10, 2014 and its Lead Director from 2012 to January 10, 2014. He served as a Director of Healthgrades Operating Company, Inc. from March 17, 2009, to October 2010. Mr. Wahlstrom served as a Director of Health Grades, Inc. from March 17, 2009, to October 2010. Mr. Wahlstrom has a B.S. degree in Economics and Business Administration from University of Lund, Sweden.
Positions
- Company NameTriSalus Life Sciences, Inc.Stock CodeTLSIPositionIndependent ChairmanRelated SecuritiesColleagues
- MTMary T. SzelaCEO, President & Director
- DBDavid B. PatienceChief Financial Officer
- RBRichard B. MarshakChief Commercial Officer
- AMAndrea MarassoVice President of Marketing
- JLJennifer L. StevensChief Regulatory, Quality and Therapeutics Officer
- KRKerry R. HicksIndependent Director
- DJDavid J. MatlinIndependent Director
- WJWilliam J. ValleIndependent Director
